George Lee
Chairman at SUNWAY BIOTECH CO., LTD.
Profile
Dr. George J.
Lee is a Chairman at Applied BioCode Corp., a Chairman at SunWay Biotech Co., Ltd., a Co-Founder & Managing Director at Amkey Ventures LLC, a Vice President at Biokey, Inc., a Chairman at Applied BioCode, Inc., a Chairman at GenePharm Biotech Corp., a Chairman at GenePharm, Inc., a Chairman at RevMAb Biosciences, Inc., a Co-Founder at Pharmdel, Inc., a Co-Founder at Pharmout Laboratories, Inc. and a Managing Director at Eureka Bioventure Partners LLC.
He is on the Board of Directors at Foresee Pharmaceuticals Co., Ltd., Cardiva Medical, Inc., Blossomhill Therapeutics, Inc., PharmTak, Inc., StemCyte, Inc. and Aulisa Medical Technologies, Inc.
Dr. Lee was previously employed as an Independent Director by Crown Bioscience, Inc., a Chairman by Epitomics, Inc., a Principal by Shaman Pharmaceuticals, Inc., a Principal by Sonus Pharmaceuticals, Inc., and a Manager-Research & Development by Syntex Corp.
He also served on the board at Apexigen America, Inc. and Turning Point Therapeutics, Inc.
He received his undergraduate degree from National Taiwan University and a doctorate degree from State University of New York at Buffalo.
George Lee active positions
| Companies | Position | Start |
|---|---|---|
| APPLIED BIOCODE CORPORATION | Chairman | 2016-06-29 |
| FORESEE PHARMACEUTICALS CO., LTD. | Director/Board Member | 2015-08-02 |
| SUNWAY BIOTECH CO., LTD. | Chairman | 2007-09-03 |
Amkey Ventures LLC
 Amkey Ventures LLC Investment ManagersFinance Amkey Ventures LLC (Amkey Ventures) is a venture capital firm founded in 2001 by George J. Lee and Woody Sing-Wood Yeh. The firm headquartered in Fremont, California. | Founder | 2010-12-27 |
| Eureka Bioventure Partners LLC | Founder | - |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Director/Board Member | - |
RevMAb Biosciences, Inc.
 RevMAb Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services RevMAb Biosciences, Inc. operates as a biotechnology company. It focuses on the development of monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation. The company is headquartered in South San Francisco, CA. | Chairman | - |
| PharmTak, Inc. | Director/Board Member | - |
| Aulisa Medical Technologies, Inc. | Director/Board Member | - |
| ░░░░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Former positions of George Lee
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of George Lee
| State University of New York at Buffalo | Doctorate Degree |
| National Taiwan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| APPLIED BIOCODE CORPORATION | Health Technology |
| FORESEE PHARMACEUTICALS CO., LTD. | Health Technology |
| SUNWAY BIOTECH CO., LTD. | Health Technology |
| Private companies | 21 |
|---|---|
| Syntex Corp. | Health Technology |
Shaman Pharmaceuticals, Inc.
 Shaman Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shaman Pharmaceuticals, Inc. engages in the discovery, development, and marketing of novel, proprietary botanical dietary supplements from tropical plant sources. The company was founded by Lisa A. Conte in May 1989 and is headquartered in San Francisco, CA. | Health Technology |
Sonus Pharmaceuticals, Inc.
 Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Health Technology |
StemCyte, Inc.
 StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Health Technology |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Health Technology |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Cardiva Medical, Inc.
 Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Cardiva Medical, Inc. designs and develops vascular access management products. It offers VASCADE, an extravascular closure device designed to increase the comfort and safety of vascular closure for patients; and Catalyst, a device that supports the body's natural healing process by enhancing the vessel's inherent natural elastic recoil, tissue apposition and coagulation. The company was founded by Zia Yassinzadeh and Augustine Y. Lien in July 2002 and is headquartered in Santa Clara, CA. | Health Technology |
Amkey Ventures LLC
Amkey Ventures LLC Investment ManagersFinance Amkey Ventures LLC (Amkey Ventures) is a venture capital firm founded in 2001 by George J. Lee and Woody Sing-Wood Yeh. The firm headquartered in Fremont, California. | Finance |
Biokey, Inc.
 Biokey, Inc. Pharmaceuticals: GenericHealth Technology Biokey, Inc. develops and markets generic drugs. Its services include regulatory support, analytical services, product development, and GMP manufacturing. The company was founded by George J. Lee in 2001 and is headquartered in Fremont, CA. | Health Technology |
GenePharm, Inc.
 GenePharm, Inc. Pharmaceuticals: MajorHealth Technology GenePharm, Inc. develops and commercializes therapeutics for skin related problems. Its services include formulation development, pre-clinical research, brand creation. technology licensing, technology alliance, and technology transfer. The company was founded in March 6, 2000 and is headquartered in the Sunnyvale, CA. | Health Technology |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Health Technology |
| Pharmout Laboratories, Inc. | |
| Eureka Bioventure Partners LLC | |
| Pharmdel, Inc. | |
| PharmTak, Inc. | |
RevMAb Biosciences, Inc.
RevMAb Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services RevMAb Biosciences, Inc. operates as a biotechnology company. It focuses on the development of monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation. The company is headquartered in South San Francisco, CA. | Commercial Services |
GenePharm Biotech Corp.
 GenePharm Biotech Corp. Pharmaceuticals: MajorHealth Technology Part of Munir Sukhtian Pharmaceuticals, GenePharm Biotech Corp. develops and commercializes preventive and curative therapeutics for skin-related problems. The private company is based in Xizhi District, Taiwan. | Health Technology |
Applied BioCode, Inc.
 Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The private company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022. | Electronic Technology |
| Aulisa Medical Technologies, Inc. | |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- George Lee
